Open Access
Open access
volume 16 issue 8 pages 1057

Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia

Galina A. Chernysheva 1
Vera I. Smol’yakova 1
Oleg I. Aliev 1
Anna M. Anishchenko 1, 3
Olga A. Ulyakhina 1
Eugene S Trofimova 1, 3
Anastasia A. Ligacheva 1
Y. J. Anfinogenova 4
Anton N. Osipenko 3
Igor A. Schepetkin 6
A. G. Drozd 7
Evgenii Plotnikov 7, 8
Dmitriy N Atochin 9
Mark T. Quinn 6
Publication typeJournal Article
Publication date2023-07-25
scimago Q1
wos Q1
SJR1.019
CiteScore7.7
Impact factor4.8
ISSN14248247
PubMed ID:  37630972
Drug Discovery
Pharmaceutical Science
Molecular Medicine
Abstract

The activation of c-Jun N-terminal kinase (JNK) plays an important role in stroke outcomes. Tryptanthrin-6-oxime (TRYP-Ox) is reported to have high affinity for JNK and anti-inflammatory activity and may be of interest as a promising neuroprotective agent. The aim of this study was to investigate the neuroprotective effects of TRYP-Ox in a rat model of transient focal cerebral ischemia (FCI), which involved intraluminal occlusion of the left middle cerebral artery (MCA) for 1 h. Animals in the experimental group were administered intraperitoneal injections of TRYP-Ox 30 min before reperfusion and 23 and 47 h after FCI. Neurological status was assessed 4, 24, and 48 h following FCI onset. Treatment with 5 and 10 mg/kg of TRYP-Ox decreased mean scores of neurological deficits by 35–49 and 46–67% at 24 and 48 h, respectively. At these doses, TRYP-Ox decreased the infarction size by 28–31% at 48 h after FCI. TRYP-Ox (10 mg/kg) reduced the content of interleukin (IL) 1β and tumor necrosis factor (TNF) in the ischemic core area of the MCA region by 33% and 38%, respectively, and attenuated cerebral edema by 11% in the left hemisphere, which was affected by infarction, and by 6% in the right, contralateral hemisphere 24 h after FCI. TRYP-Ox reduced c-Jun phosphorylation in the MCA pool at 1 h after reperfusion. TRYP-Ox was predicted to have high blood–brain barrier permeability using various calculated descriptors and binary classification trees. Indeed, reactive oxidant production was significantly lower in the brain homogenates from rats treated with TRYP-Ox versus that in control animals. Our data suggest that the neuroprotective activity of TRYP-Ox may be due to the ability of this compound to inhibit JNK and exhibit anti-inflammatory and antioxidant activity. Thus, TRYP-Ox may be considered a promising neuroprotective agent that potentially could be used for the development of new treatment strategies in cerebral ischemia.

Found 
Found 

Top-30

Journals

1
Bulletin of Experimental Biology and Medicine
1 publication, 25%
European Journal of Pharmacology
1 publication, 25%
Molecules
1 publication, 25%
International Journal of Molecular Sciences
1 publication, 25%
1

Publishers

1
2
MDPI
2 publications, 50%
Springer Nature
1 publication, 25%
Elsevier
1 publication, 25%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
4
Share
Cite this
GOST |
Cite this
GOST Copy
Plotnikov M. B. et al. Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia // Pharmaceuticals. 2023. Vol. 16. No. 8. p. 1057.
GOST all authors (up to 50) Copy
Plotnikov M. B., Chernysheva G. A., Smol’yakova V. I., Aliev O. I., Anishchenko A. M., Ulyakhina O. A., Trofimova E. S., Ligacheva A. A., Anfinogenova Y. J., Osipenko A. N., Kovrizhina A. R., Khlebnikov A. I., Schepetkin I. A., Drozd A. G., Plotnikov E., Atochin D. N., Quinn M. T. Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia // Pharmaceuticals. 2023. Vol. 16. No. 8. p. 1057.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/ph16081057
UR - https://doi.org/10.3390/ph16081057
TI - Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia
T2 - Pharmaceuticals
AU - Plotnikov, Mark B.
AU - Chernysheva, Galina A.
AU - Smol’yakova, Vera I.
AU - Aliev, Oleg I.
AU - Anishchenko, Anna M.
AU - Ulyakhina, Olga A.
AU - Trofimova, Eugene S
AU - Ligacheva, Anastasia A.
AU - Anfinogenova, Y. J.
AU - Osipenko, Anton N.
AU - Kovrizhina, Anastasia R
AU - Khlebnikov, Andrei I.
AU - Schepetkin, Igor A.
AU - Drozd, A. G.
AU - Plotnikov, Evgenii
AU - Atochin, Dmitriy N
AU - Quinn, Mark T.
PY - 2023
DA - 2023/07/25
PB - MDPI
SP - 1057
IS - 8
VL - 16
PMID - 37630972
SN - 1424-8247
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Plotnikov,
author = {Mark B. Plotnikov and Galina A. Chernysheva and Vera I. Smol’yakova and Oleg I. Aliev and Anna M. Anishchenko and Olga A. Ulyakhina and Eugene S Trofimova and Anastasia A. Ligacheva and Y. J. Anfinogenova and Anton N. Osipenko and Anastasia R Kovrizhina and Andrei I. Khlebnikov and Igor A. Schepetkin and A. G. Drozd and Evgenii Plotnikov and Dmitriy N Atochin and Mark T. Quinn},
title = {Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
publisher = {MDPI},
month = {jul},
url = {https://doi.org/10.3390/ph16081057},
number = {8},
pages = {1057},
doi = {10.3390/ph16081057}
}
MLA
Cite this
MLA Copy
Plotnikov, Mark B., et al. “Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia.” Pharmaceuticals, vol. 16, no. 8, Jul. 2023, p. 1057. https://doi.org/10.3390/ph16081057.